A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research

Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups

(2014) Billie Bonevski et al.   BMC Medical Research Methodology

Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder

(2014) A. Eden Evins et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of a Postdischarge Smoking Cessation Intervention for Smokers Admitted to an Inpatient Psychiatric Facility: A Randomized Controlled Trial

(2014) Emily A. L. Stockings et al.   NICOTINE & TOBACCO RESEARCH

Efficacy of Initiating Tobacco Dependence Treatment in Inpatient Psychiatry: A Randomized Controlled Trial

(2013) Judith J. Prochaska et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Racial differences in eligibility and enrollment in a smoking cessation clinical trial.

(2011) Andrea C. King et al.   HEALTH PSYCHOLOGY

How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey

(2011) Y. Le Strat et al.   TOBACCO CONTROL

Commentary on Banham & Gilbody (2010): The scandal of smoking and mental illness

(2010) JOHN A. STAPLETON   ADDICTION

Smoking cessation in severe mental illness: what works?

(2010) Lindsay Banham et al.   ADDICTION

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

(2007) John A. Stapleton et al.   ADDICTION